CD8+ T-cell reconstitution in recipients of umbilical cord blood transplantation and characteristics associated with leukemic relapse

Blood

Volumn 118, Issue 16, 2011, Pages 4480-4488

  Merindol, Natacha ^a,b   Champagne, Martin A ^a,b,c   Duval, Michel ^a,d   Soudeyns, Hugo ^a,b,d  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HÉMA QUÉBEC   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD45RA ANTIGEN; CHEMOKINE RECEPTOR CCR7; CORTICOSTEROID; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; HLA A2 ANTIGEN; MELAN A; PROGRAMMED DEATH 1 RECEPTOR; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE RECONSTITUTION; CELL DIFFERENTIATION; CHILD; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE ASSOCIATION; EFFECTOR CELL; FARBER DISEASE; FEMALE; GRAFT VERSUS HOST REACTION; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; HUMAN CELL; HURLER SYNDROME; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFANT; LEUKEMIA RELAPSE; LYMPHOCYTOPENIA; MALE; MEMORY T LYMPHOCYTE; MYELODYSPLASTIC SYNDROME; NEWBORN; OPPORTUNISTIC INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; WHOLE BODY RADIATION;

EID: 80054835076     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-04-349241     Document Type: Article

References (45)

1. Rubinstein P, Carrier C, Scaradavou A, et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med. 1998;339(22):1565-1577.
2. Barker JN, Wagner JE. Umbilical-cord blood transplantation for the treatment of cancer. Nat Rev Cancer. 2003;3(7):526-532.
3. Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLAmismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graftversus- host disease. Blood. 1996;88(3):795-802.
4. Thomson BG, Robertson KA, Gowan D, et al. Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood. 2000; 96(8):2703-2711.
5. Barker JN, Hough RE, van Burik JA, et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant. 2005;11(5): 362-370.
6. Merindol N, Charrier E, Duval M, Soudeyns H. Complementary and contrasting roles of NK cells and T cells in paediatric umbilical cord blood transplantation. J Leukocyte Biol. 2011;90(1):49-60.
7. Rocha V, Cornish J, Sievers EL, et al. Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood. 2001;97(10):2962-2971.
8. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood. 1997;89(10):3873-3879.
9. Eibl B, Schwaighofer H, Nachbaur D, et al. Evidence for a graft-versus-tumor effect in a patient treated with marrow ablative chemotherapy and allogeneic bone marrow transplantation for breast cancer. Blood. 1996;88(4):1501-1508.
10. Cohen G, Carter SL, Weinberg KI, et al. Antigenspecific T-lymphocyte function after cord blood transplantation. Biol Blood Marrow Transplant. 2006;12(12):1335-1342.
11. Terakura S, Azuma E, Murata M, et al. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant. 2007;13(7):822-830.
12. Guérin-El Khourouj V, Dalle JH, Pédron B, et al. Quantitative and qualitative CD4 T cell immune responses related to adenovirus DNAemia in hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17(4):476-485.
13. Tormo N, Solano C, Benet I, et al. Reconstitution of CMV pp65 and IE-1-specific IFN-gamma CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT. Bone Marrow Transplant. Prepublished on January 17, 2011, as DOI 10.1038/bmt.2010.330.
14. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature. 1999;401(6754): 708-712.
15. Merindol N, Grenier AJ, Caty M, et al. Umbilical cord blood T cells respond against the Melan-A/ MART-1 tumor antigen and exhibit reduced alloreactivity as compared with adult blood-derived T cells. J Immunol. 2010;185(2):856-866.
16. Harari A, Dutoit V, Cellerai C, Bart PA, Du Pasquier RA, Pantaleo G. Functional signatures of protective antiviral T-cell immunity in human virus infections. Immunol Rev. 2006;211: 236-254.
17. Romero P, Valmori D, Pittet MJ, et al. Antigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma. Immunol Rev. 2002;188:81-96.
18. Alanio C, Lemaitre F, Law HK, Hasan M, Albert ML. Enumeration of human antigenspecific naive CD8+ T cells reveals conserved precursor frequencies. Blood. 2010;115(18): 3718-3725.
19. Dalle JH, Duval M, Moghrabi A, et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant. 2004;33(6): 605-611.
20. Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Isolation of high avidity melanomareactive CTL from heterogeneous populations using peptide-MHC tetramers. J Immunol. 1999;162(4):2227-2234.
21. Brunner KT, Mauel J, Cerottini JC, Chapuis B. Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and by drugs. Immunology. 1968;14(2):181-196.
22. Soudeyns H, Champagne P, Holloway CL, et al. Transient T cell receptor beta-chain variable region- specific expansions of CD4+ and CD8+ T cells during the early phase of pediatric human immunodeficiency virus infection: characterization of expanded cell populations by T cell receptor phenotyping. J Infect Dis. 2000;181(1):107-120.
23. Brochet X, Lefranc MP, Giudicelli V. IMGT/ V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. 2008;36(Web Server issue):W503-W508.
24. Venturi V, Kedzierska K, Turner SJ, Doherty PC, Davenport MP. Methods for comparing the diversity of samples of the T cell receptor repertoire. J Immunol Methods. 2007;321(1-2):182-195.
25. Rénard C, Barlogis V, Mialou V, et al. Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children. Br J Haematol. 2011;152(3):322-330.
26. Currier JR, Deulofeut H, Barron KS, Kehn PJ, Robinson MA. Mitogens, superantigens, and nominal antigens elicit distinctive patterns of TCRB CDR3 diversity. Hum Immunol. 1996;48(1-2):39-51.
27. Betts MR, Nason MC, West SM, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006; 107(12):4781-4789.
28. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677-704.
29. Ssewanyana I, Baker CA, Ruel T, et al. The distribution and immune profile of T cell subsets in HIV-infected children from Uganda. AIDS Res Hum Retroviruses. 2009;25(1):65-71.
30. Grabmeier-Pfistershammer K, Steinberger P, Rieger A, Leitner J, Kohrgruber N. Identification of PD-1 as a unique marker for failing immune reconstitution in HIV-1-infected patients on treatment. J Acquir Immune Defic Syndr. 2011;56(2): 118-124.
31. Parkman R, Cohen G, Carter SL, et al. Successful immune reconstitution decreases leukemic relapse and improves survival in recipients of unrelated cord blood transplantation. Biol Blood Marrow Transplant. 2006;12(9):919-927.
32. Scheinberg P, Melenhorst JJ, Brenchley JM, et al. The transfer of adaptive immunity to CMV during hematopoietic stem cell transplantation is dependent on the specificity and phenotype of CMVspecific T cells in the donor. Blood. 2009;114(24): 5071-5080.
33. Fujiwara H, El Ouriaghli F, Grube M, et al. Identification and in vitro expansion of CD4+ and CD8+ T cells specific for human neutrophil elastase. Blood. 2004;103(8):3076-3083.
34. Rezvani K, Grube M, Brenchley JM, et al. Functional leukemia-associated antigen-specific memory CD8+ T cells exist in healthy individuals and in patients with chronic myelogenous leukemia before and after stem cell transplantation. Blood. 2003;102(8):2892-2900.
35. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 2002;99(4):1458-1464.
36. Komanduri KV, St John LS, de Lima M, et al. Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. Blood. 2007;110(13):4543-4551.
37. Yakoub-Agha I, Saule P, Magro L, et al. Immune reconstitution following myeloablative allogeneic hematopoietic stem cell transplantation: the impact of expanding CD28 negative CD8+ T cells on relapse. Biol Blood Marrow Transplant. 2009; 15(4):496-504.
38. Poulin JF, Viswanathan MN, Harris JM, et al. Direct evidence for thymic function in adult humans. J Exp Med. 1999;190(4):479-486.
39. Harris JM, Hazenberg MD, Poulin JF, et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol. 2005;115(2):138-146.
40. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 2006;443(7109):350-354.
41. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 2006;439(7077): 682-687.
42. Mumprecht S, Schürch C, Schwaller J, Solenthaler M, Ochsenbein AF. Programmed death 1 signaling on chronic myeloid leukemiaspecific T cells results in T-cell exhaustion and disease progression. Blood. 2009;114(8):1528-1536.
43. Gallez-Hawkins GM, Thao L, Palmer J, et al. Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graftversus-host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2009;15(7):872-880.
44. Appay V, van Lier RA, Sallusto F, Roederer M. Phenotype and function of human T lymphocyte subsets: consensus and issues. Cytometry A. 2008;73(11):975-983.
45. Duraiswamy J, Ibegbu CC, Masopust D, et al. Phenotype, function, and gene expression profiles of programmed death-1hi CD8 T cells in healthy human adults. J Immunol. 2011;186(7): 4200-4212.